Publications
Showing all 327 journal articles & 26 books available
Journal Articles
1/22/2022
Kerns SL, Amidon Morlang A, Lee SM, Peterson DR, Marples B, Zhang H, Bylund K, Rosenzweig D, Hall W, De Ruyck K, Rosenstein BS, Stock RG, Gómez-Caamaño A, Vega A, Sosa-Fajardo P, Taboada-Valladares B, Aguado-Barrera ME, Parker C, Veldeman L, Fonteyne V, Bultijnck R, Talbot CJ, Paul Symonds R, Johnson K, Rattay T, Webb A, Lambrecht M, de Ruysscher D, Vanneste B, Choudhury A, Elliott RM, Sperk E, Herskind C, Veldwijk MR, Rancati T, Avuzzi B, Valdagni R, Azria D, Farcy Jacquet MP, Chang-Claude J, Seibold P, West C, Janelsins M, Chen Y, Messing E, Morrow G, . "Use of Angiotensin Converting Enzyme Inhibitors is Associated with Reduced Risk of Late Bladder Toxicity Following Radiotherapy for Prostate Cancer." Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.. 2022 Jan 22; Epub 2022 Jan 22.
2022
Zhang H, Yang H, Bandyopadhyay S, Milano MT, Fung C, Messing EM, Chen Y. "Increased risk of high-grade prostate cancer among testicular cancer survivors." PloS one.. 2022 17(2):e0263573. Epub 2022 Feb 14.
5/2021
Ellis EE, Messing EM. "Active Surveillance of Small Renal Masses: A Systematic Review". Kidney Cancer. 2021; .
3/8/2021
Correa AF, Jegede OA, Haas NB, Flaherty KT, Pins MR, Adeniran A, Messing EM, Manola J, Wood CG, Kane CJ, Jewett MAS, Dutcher JP, DiPaola RS, Carducci MA, Uzzo RG. "Predicting Disease Recurrence, Early Progression, and Overall Survival Following Surgical Resection for High-risk Localized and Locally Advanced Renal Cell Carcinoma." European urology.. 2021 Mar 8; Epub 2021 Mar 08.
2021
Zhang, H; Yu, A; Baran, A; Messing, E. ""Risk of Second Cancer among Young Prostate Cancer Survivors" . Radiation Oncology Journal. 2021; in press." Radiation Oncology Journal. 2021; in press. 2021; .
9/2020
Osinski T, Campbell T, Gantz J, Nelson B, Feng C, Messing EM,. "Oncologic Outcomes After Partial Cystectomy for Urethiel Cancer". Canadian Urology Association Journal. 2020; 9(3): S169-S232.
7/15/2020
Gurung PMS, Barnett AR, Wilson JS, Hudson J, Ward DG, Messing EM, Bryan RT. "Prognostic DNA Methylation Biomarkers in High-risk Non-muscle-invasive Bladder Cancer: A Systematic Review to Identify Loci for Prospective Validation." European urology focus.. 2020 Jul 15; 6(4):683-697. Epub 2019 Feb 23.
5/16/2020
Matulay JT, Tabayoyong W, Duplisea JJ, Chang C, Daneshmand S, Gore JL, Holzbeierlein JM, Karsh LI, Kim SP, Konety BR, Li R, McKiernan JM, Messing EM, Steinberg GD, Williams SB, Kamat AM. "Variability in adherence to guidelines based management of nonmuscle invasive bladder cancer among Society of Urologic Oncology (SUO) members." Urologic oncology.. 2020 May 16; Epub 2020 May 16.
5/2020
Jubber I, Shariat SF, Conroy S, Tan WS, Gordon PC, Lotan Y, Messing EM, Stenzl A, Rhijn BV, Kelly JD, Catto JWF, Cumberbatch MG. "Non-visible haematuria for the Detection of Bladder, Upper Tract, and Kidney Cancer: An Updated Systematic Review and Meta-analysis." European urology.. 2020 May; 77(5):583-598. Epub 2019 Nov 30.
4/2020
Lee Z, Jegede OA, Haas NB, Pins MR, Messing EM, Manola J, Wood CG, Kane CJ, Jewett MAS, Flaherty KT, Dutcher JP, DiPaola RS, Uzzo RG. "Local Recurrence Following Resection of Intermediate-High Risk Nonmetastatic Renal Cell Carcinoma: An Anatomical Classification and Analysis of the ASSURE (ECOG-ACRIN E2805) Adjuvant Trial." The Journal of urology.. 2020 Apr; 203(4):684-689. Epub 2019 Oct 09.
2/2020
Gurung PMS, Messing EM, Joseph JV, Wu G. "EDITORIAL COMMENT." Urology.. 2020 Feb; 136:110-111.
1/27/2020
Lemke E, Sahasrabudhe D, Guancial E, Bylow K, Johnson S, Messing E, Kilari D. "The Role of Metastasectomy in Urothelial Carcinoma: Where Are We in 2020?" Clinical genitourinary cancer.. 2020 Jan 27; Epub 2020 Jan 27.
11/2019
Lotan Y, Inman BA, Davis LG, Kassouf W, Messing E, Daneshmand S, Canter D, Marble HT, Joseph AM, Jewell S, Boorjian SA. "Evaluation of the Fluorescence In Situ Hybridization Test to Predict Recurrence and/or Progression of Disease after bacillus Calmette-Guérin for Primary High Grade Nonmuscle Invasive Bladder Cancer: Results from a Prospective Multicenter Trial." The Journal of urology.. 2019 Nov; 202(5):920-926. Epub 2019 Oct 09.
9/10/2019
Chen J, Chou F, Yeh S, Ou Z, Shyr C, Huang C, Xiang Z, Sun Y, Messing E, Zu X, Chang C. "Androgen dihydrotestosterone (DHT) promotes the bladder cancer nuclear AR-negative cell invasion via a newly identified membrane androgen receptor (mAR-SLC39A9)-mediated G?i protein/MAPK/MMP9 intracellular signaling." Oncogene.. 2019 Sep 10; Epub 2019 Sep 10.
9/2019
Gurung PMS, Messing EE, Joseph JV. "EDITORIAL COMMENT." Urology.. 2019 Sep; 131:118-119.
8/10/2019
Correa AF, Jegede O, Haas NB, Flaherty KT, Pins MR, Messing EM, Manola J, Wood CG, Kane CJ, Jewett MAS, Dutcher JP, DiPaola RS, Carducci MA, Uzzo RG. "Predicting Renal Cancer Recurrence: Defining Limitations of Existing Prognostic Models With Prospective Trial-Based Validation." Journal of clinical oncology : official journal of the American Society of Clinical Oncology.. 2019 Aug 10; 37(23):2062-2071. Epub 2019 Jun 19.
7/26/2019
Messing E, Doyle PJ, Meyer H, Li D, Lee TG, Lipetskaia L. "Pelvic Floor Organ Prolapse After Radical Cystectomy in Patients With Uroepithelial Carcinoma." Female pelvic medicine & reconstructive surgery.. 2019 Jul 26; Epub 2019 Jul 26.
6/24/2019
Huang CP, Chen J, Chen CC, Liu G, Zhang Y, Messing E, Yeh S, Chang C. "ASC-J9® increases the bladder cancer chemotherapy efficacy via altering the androgen receptor (AR) and NF-?B survival signals." Journal of experimental & clinical cancer research : CR.. 2019 Jun 24; 38(1):275. Epub 2019 Jun 24.
5/2019
Truong M, Baack Kukreja JE, Rais-Bahrami S, Barashi NS, Wang B, Nuffer Z, Park JH, Lam K, Frye TP, Nix JW, Thomas JV, Feng C, Chapin BF, Davis JW, Hollenberg G, Oto A, Eggener SE, Joseph JV, Weinberg E, Messing EM. "Multi-institutional Clinical Tool for Predicting High-risk Lesions on 3Tesla Multiparametric Prostate Magnetic Resonance Imaging." European urology oncology.. 2019 May; 2(3):257-264. Epub 2019 Jan 04.
3/2019
Berrondo C, Feng C, Kukreja JB, Messing EM, Joseph JV. "Antibiotic prophylaxis at the time of catheter removal after radical prostatectomy: A prospective randomized clinical trial." Urologic oncology.. 2019 Mar; 37(3):181.e7-181.e14. Epub 2018 Dec 14.
1/2019
Leow JJ, Bedke J, Chamie K, Collins JW, Daneshmand S, Grivas P, Heidenreich A, Messing EM, Royce TJ, Sankin AI, Schoenberg MP, Shipley WU, Villers A, Efstathiou JA, Bellmunt J, Stenzl A. "SIU-ICUD consultation on bladder cancer: treatment of muscle-invasive bladder cancer." World journal of urology.. 2019 Jan; 37(1):61-83. Epub 2019 Jan 25.
2019
Kim, HL; Mayerson, E; Lara, PN; Messing, EM; Tangen, C; Shuch, BM; Vaishampayan, U. ""Considerations for the Next Clinical Trial Evaluating the Role of Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma"". Eur Urol Focus. 2019; 5 (6)(doi: 10.1016/j.euf.2019.05.006.): 927-929.
12/28/2018
Wu CH, Silvers CR, Messing EM, Lee YF. "Bladder cancer extracellular vesicles drive tumorigenesis by inducing the unfolded protein response in endoplasmic reticulum of non-malignant cells." The Journal of biological chemistry.. 2018 Dec 28; Epub 2018 Dec 28.
11/2018
Brummelhuis ISG, Witjes JA, Messing EM. "The conundrum of recurrent low-grade tumours: to treat or to observe?" Current opinion in urology.. 2018 Nov; 28(6):557-562.
10/29/2018
Messing EM. "Perioperative Blood Transfusions and Bladder Cancer Outcomes." Bladder cancer.. 2018 Oct 29; 4(4):445-446. Epub 2018 Oct 29.
8/28/2018
Tao L, Qiu J, Slavin S, Ou Z, Liu Z, Ge J, Guancial EA, Messing EM, Chang C, Yeh S. "Recruited T cells promote the bladder cancer metastasis via up-regulation of the estrogen receptor ?/IL-1/c-MET signals." Cancer letters.. 2018 Aug 28; 430:215-223. Epub 2018 Apr 22.
8/2018
Truong M, Frye T, Messing E, Miyamoto H. "Historical and contemporary perspectives on cribriform morphology in prostate cancer." Nature reviews. Urology.. 2018 Aug; 15(8):475-482.
8/2018
Messing EM. "Legends in Urology." The Canadian journal of urology.. 2018 Aug; 25(4):9367-9369.
7/30/2018
Messing EM. "Financial Toxicity of Having Bladder Cancer." Bladder cancer.. 2018 Jul 30; 4(3):351-352. Epub 2018 Jul 30.
5/8/2018
Messing EM, Tangen CM, Lerner SP, Sahasrabudhe DM, Koppie TM, Wood DP, Mack PC, Svatek RS, Evans CP, Hafez KS, Culkin DJ, Brand TC, Karsh LI, Holzbeierlein JM, Wilson SS, Wu G, Plets M, Vogelzang NJ, Thompson IM. "Effect of Intravesical Instillation of Gemcitabine vs Saline Immediately Following Resection of Suspected Low-Grade Non-Muscle-Invasive Bladder Cancer on Tumor Recurrence: SWOG S0337 Randomized Clinical Trial." JAMA.. 2018 May 8; 319(18):1880-1888.
4/26/2018
Messing EM. "Psychological Stress and Suicide in Bladder Cancer Patients." Bladder cancer.. 2018 Apr 26; 4(2):245-246. Epub 2018 Apr 26.
3/2018
Nguyen HG, Welty C, Lindquist K, Ngo V, Gilbert E, Bengtsson H, Magi-Galluzzi C, Jean-Gilles J, Yao J, Cooperberg M, Messing E, Klein EA, Carroll PR, Paris PL. "Validation of GEMCaP as a DNA Based Biomarker to Predict Prostate Cancer Recurrence after Radical Prostatectomy." The Journal of urology.. 2018 Mar; 199(3):719-725. Epub 2017 Sep 20.
1/20/2018
Messing EM. "Molecular Landscape of Non-Muscle Invasive Bladder Cancer." Bladder cancer.. 2018 Jan 20; 4(1):131-132. Epub 2018 Jan 20.
1/15/2018
Truong M, Wang B, Gordetsky JB, Nix JW, Frye TP, Messing EM, Thomas JV, Feng C, Rais-Bahrami S. "Multi-institutional nomogram predicting benign prostate pathology on magnetic resonance/ultrasound fusion biopsy in men with a prior negative 12-core systematic biopsy." Cancer.. 2018 Jan 15; 124(2):278-285. Epub 2017 Oct 04.
1/2018
Ristau BT, Manola J, Haas NB, Heng DYC, Messing EM, Wood CG, Kane CJ, DiPaola RS, Uzzo RG. "Retroperitoneal Lymphadenectomy for High Risk, Nonmetastatic Renal Cell Carcinoma: An Analysis of the ASSURE (ECOG-ACRIN 2805) Adjuvant Trial." The Journal of urology.. 2018 Jan; 199(1):53-59. Epub 2017 Jul 18.
1/2018
Truong M, Feng C, Hollenberg G, Weinberg E, Messing EM, Miyamoto H, Frye TP. "A Comprehensive Analysis of Cribriform Morphology on Magnetic Resonance Imaging/Ultrasound Fusion Biopsy Correlated with Radical Prostatectomy Specimens." The Journal of urology.. 2018 Jan; 199(1):106-113. Epub 2017 Jul 18.
10/31/2017
Silvers CR, Miyamoto H, Messing EM, Netto GJ, Lee YF. "Characterization of urinary extracellular vesicle proteins in muscle-invasive bladder cancer." Oncotarget.. 2017 Oct 31; 8(53):91199-91208. Epub 2017 Aug 08.
4/2016
Silvers CR, Liu YR, Wu CH, Miyamoto H, Messing EM, Lee YF. "Identification of extracellular vesicle periostin as a urinary biomarker of muscle invasive bladder cancer progression". Oncotarget. 2016; Apr 26;7(17):23335-45.
4/2016
Baack Kukreja JE, Kiernan M, Schempp B, Siebert A, Hontar A, Dolan J, Noyes K, Dozier A, Ghazi A, Rashid HH, Wu G, Messing. "Quality improvement in cystectomy care with enhanced
recovery (QUICCER Study)". EMBJU Int. 2016; April 29.
4/2016
Shang Z, Li Y, Hsu I, Zhang M, Tian J, Wen S, Han R, Messing EM, Chang C, Niu Y, Yeh S. "Targeting estrogen/estrogen receptor alpha will enhance Bacillus Calmette-Guerin efficacy in bladder cancer". Oncotarget. 2016; 15doi: 10.18632/oncotarget.8756.
3/2016
Baack Kukreja JE, Messing EM, Shah JB. "Are we doing "better? The discrepancy between
perception and practice of enhanced recovery after cystectomy principles among urologic oncologists". Urol Oncol. 2016; 34(3):120.e17-21.
2/2016
Kilari D, Iczkowski KA, Pandya C, Robin AJ, Messing EM, Guancial E, Kim ES . "Copper transporter-CTR1 expression and pathological outcomes in platinum-treated muscle-invasive bladder cancer patients". Anticancer Res. 2016; 36(2):495-501.
1/2016
Messing, EM. "Bladder cancer". Paper Alert. 2016; Jan 28;2(1):123-125.
2016
Lee YF, Silvers C, Liu Y-R, Wu C-H, Miyamoto H, Messing E. "Identification of extracellular vesicle periostin as a urinary biomarker of muscle invasive bladder cancer progression". Oncotarget. 2016; 7(17): 23335-23345.
2016
Messing EM. "Paper Alert". Bladder Cancer. 2016; Apr 27;2(2):283-284.
2016
Ramirez D, Gupta A, Canter D, Harrow B, Dobbs RW, Kucherov V, Mueller E, Streeper N, Uhlman MA, Svatek RS, Messing EM, Lotan Y. "Microscopic haematuria at time of diagnosis is associated
with lower disease stage in patients with newly diagnosed bladder cancer". BJU Int. 2016; May;117(5):783-6.
2016
Guancial EA, Kilari D, Xiao G-Q, Abu-Farsakh SH, Baran A, Messing EM, Kim ES. "Platinum concentration and pathologic response to cisplatin-based neoadjuvant chemotherapy in muscle-invasive bladder cancer". PLoS One. 2016; May 17;11(5) e0155503.(doi: 0.1371/journal.pone.0155503).
2016
Messing EM. "Editorial Comment. Risk factors and microbial distribution of urinary tract infections following radical cystectomy". Urology. 2016; May 20 pii:S0090-4295(16)30118-2.
2016
Messing EM . "Editorial Comment. Risk factors and microbial distribution of urinary tract infections following radical cystectomy". Urology. 2016; pii: S0090-4295(16)30118-2.
2016
Gee JR, Saltzstein DR, Messing E, Kim K, Kolesar J, Huang W, Havighurst TC, Harris L, Wollmer BW, Jarrard D, House M, Parnes H, Bailey HH. "Phase Ib placebo-controlled, tissue biomarker trial of
diindolylmethane (BR_DIMNG) in patients with prostate cancer who are undergoing prostatectomy". Eur J Cancer Prev. 2016; Jul;25(4):312-20.
11/2015
Kukreja JB, Messing EM. "Editorial Comment". Urology. 2015; 86(5):972-3.
9/2015
Ptaszynska A, Cohen SM, Messing EM, Reilly TP, Johnsson E, Johnsson K. "Assessing bladder cancer risk in type 2 diabetes clinical trials: the dapagliflozin drug development program as a 'case
study'". Springer Healthcare/inScience Communications
Diabetes Ther. 2015; 6(3):357-75.
9/2015
Baack Kukreja JE, Levey HR, Scosyrev E, Kiernan M, Berrondo C, McNamee C, Wu G, Joseph JV, Ghazi A, Rashid H, Dozier A, Messing EM. "Effectiveness and safety of extended duration
prophylaxis for venous thromboembolism in major urologic oncology surgery". Urol Oncol. 2015; 33(9):387.
7/2015
Rojas KD, Montero ML, Yao JL, Messing EM, Fazili AA, Joseph J, Ou Y, Rubens D, Parker KJ, Davatzikos C, Castaneda B. "Methodology to study the 3D spatial distribution of prostate cancer and their dependence on clinical parameters". J Med Imaging (Bellingham). 2015; 2(3):037502.
2015
Apolo AB, Hoffman V, Kaag MG, Latini DM, Lee CT, Rosenberg JE, Knowles M, Theodorescu D, Czerniak BA, Efstathiou JA, Albert ML, Sridhar SS, Margulis V, Matin SF, Galsky MD, Hansel D, Kamat AM, Flaig TW, Smith AB, Messing E, Zipursky Quale D, Lotan Y. "Summary of the 8th annual Bladder cancer think tank: collaborating to move research forward". Urol Oncol. 2015; 33(2): 53-64.
2015
Guancial EA, Roussel B, Bergsma DP, Bylund KC, Sahasrabudhe D, Messing E, Mohile SG, Fung C. "Bladder cancer in the elderly patient: challenges and solutions". Clinical Interventions in Aging. 2015; 10: 939-949.
2015
Ptaszynska A, Cohen SM, Messing EM, Reilly TP, Johnsson E, Johnsson K. "Assessing bladder cancer risk in type 2 diabetes clinical trials: the dapagliflozin drug development program as a 'case study'". Springer Healthcare/inScience Communications/Diabetes Ther. 2015; 6(3): 357-375.
2015
Baack Kukreja JE, Levey HR, Scosyrev E, Kiernan M, Berrondo C, McNamee C, Wu G, Joseph JV, Ghazi A, Rashid H, Dozier A, Messing EM. "Effectiveness and safety of extended duration prophylaxis for venous thromboembolism in major urologic oncology surgery". Urologic Oncology. 2015; 33(9): 387.e7-387e.16.
2015
Diaz Rojas KE, Montero ML, Yao JL, Messing EM, Fazili AA, Joseph J, Ou Y, Rubens D, Parker KJ, Davatzikos C, Castaneda B. "Methodology to study the 3D spatial distribution of prostate cancer and their dependence on clinical parameters". Journal of Medical Imaging. 2015; 2(3): 037502.
2015
Shang Z, Li Y, Zhang M, Tian J, Han R, Shyr CR, Messing E, Yeh S, Niu Y, Chang C. "Anti-androgen therapy with Hydroxyflutamide or androgen receptor degradation enhancer ASC-J9® enhances BCG efficacy to better suppress bladder cancer progression". Mol Cancer Ther. 2015; 11; pii: molcanther.1055,([Epub ahead of print]).
1/2014
Donsky H, Coyle S, Scosyrev E, Messing EM. "Sex differences in incidence and mortality of bladder
and kidney cancers: National estimates from 49 countries". Urologic Oncology. 2014; 32(1):40.
2014
Dunne RF, Sahasrabudhe DM, Messing EM, Jean-Gilles J, Fung C. "A case series of transformation
of teratoma to primitive neuroectodermal tumor: evolving management of a rare malignancy". Rare Tumors. 2014; 6(1): 5208.
2014
Abern MR, Scosyrev E, Tsivian M, Messing EM, Polascik TJ, Dudek AZ. "Survival of patients undergoing cytoreductive surgery for metastatic renal cell carcinoma in the targeted therapy era". Anticancer Research. 2014; (34): 2405-2412.
2014
Scosyrev E, Wu K, Levey HR, Agrawal V, Beckham C, Wu G, Messing. "Overall survival after partial versus radical nephrectomy for a small renal mass: systematic review of observational
studies". EUrology Practice. 2014; (1): 27-34.
2014
Scosyrev E, Messing EM, Sylvester R, Campbell S, Van Poppel H. "Renal function after nephron-sparing surgery versus radical nephrectomy: results from EORTC randomized trial 30904". European Urology. 2014; 65(2): 372-377.
2014
Kolesar JM, Pomplun M, Havighurst T, Stublaski J, Wollmer B, Kim K, Tangrea JA, Parnes HL, House MG, Gee J, Messing E, Bailey HH. "Soy food frequency questionnaire does not correlate with
baseline isoflavone levels in patients with bladder cancer". J Oncol Pharm Pract. 2014; .
2014
Slavin S, Yeh CR, Jun D, Yu S, Miyamoto H, Messing EM, Yeh S. "Estrogen Receptor ? in Cancer Associated Fibroblasts Suppresses Prostate Cancer Invasion via Modulation of Thrombospondin-2 and Matrix Metalloproteinase 3". Carcinogenesis. 2014; 35(6): 1301-9.
2014
Messing EM. "Gender disparities in hematuria evaluation and bladder cancer diagnosis: a population based analysis (Editorial Comment)". J Urol. 2014; : 101.
2014
Krabbe LM, Svatek RS, Shariat SF, Messing E, Lotan Y. "Bladder cancer risk: use of the PLCO and NLST to identify a suitable screening cohort". Urol Oncol. 2014; : 65.e19-65.e25.
2014
Willis DK, Flaig TW, Hansel DE, Milowsky MI, Grubb RL, Al-Ahmadie HA, Plimack ER, Koppie TN, McConkey DJ, Dinney CP, Hoffman VA, Droller MJ, Messing E, Kamat AM. "Micropapillary bladder cancer: current treatment patterns and review of the literature". Urol Oncol. 2014; 32(6): 826-32.
2014
Beckham C, Olsen J, Yin PN, Wu CH, Ting HJ, Hagen F, Scosyrev E, Messing E, Lee YF. "Bladder Cancer Exosomes Contain EDIL-3/Del1 and Facilitate Cancer Progression". J of Urology. 2014; 192(3): 690-695.
2014
Fung C, Pandya C, Noyes K, Scosyrev E, Sahasrabudhe DM, Messing EM, Mohile SG. "Impact of Bladder Cancer (BC) on Health-related Quality of Life (HRQL) in 1,476 Older Americans". J Urol. 2014; 192(3): 690-695.
2014
Hsu I, Yeh CR, Slavin S, Miyamoto H, Netto GJ, Tsai YC, Muyan M, Wu XR, Messing EM, Guancial EA, Yeh S. "Estrogen receptor alpha prevents bladder cancer via INPP4B inhibited akt pathway in vitro and in vivo". Oncotarget. 2014; 5(17): 7917-35.
2014
Yasmin-Karim S, King MR, Messing EM, Lee YF
. "E-selectin ligand-1 controls circulating prostate cancer cell rolling/adhesion and metastasis". Oncotarget. 2014; 5(23): 12097-110.
2014
Baack Kukreja J, Scosyrev E, Brasacchio RA, Toy EP, Messing EM, Wu G. "Bladder cancer incidence and mortality in patients treated with radiation for uterine cancer". BJUI. 2014; 114: 844-851.
7/2013
Scosyrev E, Wu G, Golijanin D, Messing E. "Non-bladder cancer mortality in patients with urothelial cancer of the bladder." Urologic oncology.. 2013 Jul; 31(5):656-63. Epub 2011 May 07.
6/2013
Larré S, Catto JW, Cookson MS, Messing EM, Shariat SF, Soloway MS, Svatek RS, Lotan Y, Zlotta AR, Grossman HB. "Screening for bladder cancer: rationale, limitations, whom to target, and perspectives." European urology.. 2013 Jun; 63(6):1049-58. Epub 2013 Jan 08.
5/2013
Yang DR, Lin SJ, Ding XF, Miyamoto H, Messing E, Li LQ, Wang N, Chang C. "Higher expression of peroxisome proliferator-activated receptor ? or its activation by agonist thiazolidinedione-rosiglitazone promotes bladder cancer cell migration and invasion." Urology.. 2013 May; 81(5):1109.e1-6. Epub 2013 Mar 19.
4/2013
Weight CJ, Miller DC, Campbell SC, Derweesh IH, Lane BR, Messing EM. "The management of a clinical t1b renal tumor in the presence of a normal contralateral kidney." The Journal of urology.. 2013 Apr; 189(4):1198-202. Epub 2013 Jan 18.
3/1/2013
Scosyrev E, Messing EM. "Reply to prostate-specific antigen screening for prostate cancer and the risk of overt metastatic disease at presentation : analysis of trends over time." Cancer.. 2013 Mar 1; 119(5):1113-4. Epub 2012 Oct 23.
3/2013
Scosyrev E, Tobis S, Donsky H, Wu G, Joseph J, Rashid H, Messing E. "Statin use and the risk of biochemical recurrence of prostate cancer after definitive local therapy: a meta-analysis of eight cohort studies." BJU international.. 2013 Mar; 111(3 Pt B):E71-7. Epub 2012 Sep 27.
2/2013
Shyr CR, Chen CC, Hsieh TF, Chang CH, Ma WL, Yeh S, Messing E, Li TH, Li FY, Chang C. "The expression and actions of androgen receptor in upper urinary tract urothelial carcinoma (UUTUC) tissues and the primary cultured cells." Endocrine.. 2013 Feb; 43(1):191-9. Epub 2012 Aug 01.
2/2013
Ghazi A, Scosyrev E, Patel H, Messing EM, Joseph JV. "Complications associated with extraperitoneal robot-assisted radical prostatectomy using the standardized Martin classification." Urology.. 2013 Feb; 81(2):324-31.
2013
Campbell SC, Derweesh IH, Lane BR, Messing EM. "The management of a clinical T1b renal tumor in the presence of a normal contralateral kidney: The case for nephron-sparing surgery". Urology. 2013; 189.
2013
Borch M, Scosyrev E, Baron B, Encarnacion J, Smith EM, Messing E. "A randomized trial of 2% lidocaine gel versus plain lubricating gel for minimizing pain in men undergoing flexible
cystoscopy". Urologic Nursing. 2013; 33(4).
2013
Messing, EM. "PSA screening for prostate cancer". Doctor's Advice - Monroe County Medical Society. 2013; .
2013
Dogra VS, Chinni BK, Valluru KS, Joseph JV, Ghazi A, Yao JL, Evans K, Messing EM, Rao NA. "Multispectral photoacoustic imaging of prostate cancer: preliminary ex-vivo results". J Clin Imaging Sci. 2013; .
2013
Dogra VS, Chinni BK, Valluru KS, Joseph JV, Ghazi A, Yao JL, Evans K, Messing EM, Rao NA. "Multispectral photoacoustic imaging of prostate cancer: preliminary ex-vivo results". J Clin Imaging Sci. 2013; .
2013
Zhang H, Messing EM, Travis LB, Hyrien O, Chen R, Milano MT, Chen Y. "Age and racial differences among PSA-detected (AJCC stage T1cN0M0) prostate cancer in the U.S.: a population-based study of 70,345 men". Frontiers in Oncology. 2013; Volume 3:312.
2013
Hsu JW, Yin PN, Wood R, Messing J, Messing E, Lee YF. "1 alpha, 25-dihydroxylvitamin D3 promotes Bacillus Calmette-Guérin immunotherapy of bladder cancer". Oncotarget. 2013; 4(12): 2397-2406.
2013
Scosyrev E, Messing EM. "Radical versus partial nephrectomy for a small renal mass: does saving nephrons save lives?". Expert Reviews of Anticancer Therapy. 2013; 13(12):1349-51.
2013
Messing EM. "N+M0 prostate cancer: local therapy for systemic disease". Oncology (Williston Park). 2013; 27(7): 661-2, 668.
12/1/2012
Scosyrev E, Wu G, Mohile S, Messing EM. "Prostate-specific antigen screening for prostate cancer and the risk of overt metastatic disease at presentation: analysis of trends over time." Cancer.. 2012 Dec 1; 118(23):5768-76. Epub 2012 Jul 30.
12/2012
Davis R, Jones JS, Barocas DA, Castle EP, Lang EK, Leveillee RJ, Messing EM, Miller SD, Peterson AC, Turk TM, Weitzel W, . "Diagnosis, evaluation and follow-up of asymptomatic microhematuria (AMH) in adults: AUA guideline." The Journal of urology.. 2012 Dec; 188(6 Suppl):2473-81. Epub 2012 Oct 24.
11/2012
Scosyrev E, Wu G, Golijanin D, Messing E. "Prostate-specific antigen testing in older men in the USA: data from the behavioral risk factor surveillance system." BJU international.. 2012 Nov; 110(10):1485-90. Epub 2012 Mar 27.
11/2012
Messing EM. "Words of wisdom. Re: Preexisting BCG-specific T cells improve intravesical immunotherapy for bladder cancer." European urology.. 2012 Nov; 62(5):935-6.
9/2012
Baran TM, Wilson JD, Mitra S, Yao JL, Messing EM, Waldman DL, Foster TH. "Optical property measurements establish the feasibility of photodynamic therapy as a minimally invasive intervention for tumors of the kidney." Journal of biomedical optics.. 2012 Sep; 17(9):98002-1.
8/16/2012
Byler TK, Leocadio D, Shapiro O, Bratslavsky G, Stodgell CJ, Wood RW, Messing EM, Reeder JE. "Valproic acid decreases urothelial cancer cell proliferation and induces thrombospondin-1 expression." BMC urology.. 2012 Aug 16; 12:21. Epub 2012 Aug 16.
6/15/2012
Scosyrev E, Messing EM, Mohile S, Golijanin D, Wu G. "Prostate cancer in the elderly: frequency of advanced disease at presentation and disease-specific mortality." Cancer.. 2012 Jun 15; 118(12):3062-70. Epub 2011 Oct 17.
6/2012
Miyamoto H, Yao JL, Chaux A, Zheng Y, Hsu I, Izumi K, Chang C, Messing EM, Netto GJ, Yeh S. "Expression of androgen and oestrogen receptors and its prognostic significance in urothelial neoplasm of the urinary bladder." BJU international.. 2012 Jun; 109(11):1716-26. Epub 2012 Jan 05.
4/2012
Lloyd GL, Singh MJ, Messing EM. "An unusual cause of an enhancing retroperitoneal mass." Urology.. 2012 Apr; 79(4):e61-2. Epub 2011 Sep 25.
4/2012
Messing E, Gee JR, Saltzstein DR, Kim K, Disant'agnese A, Kolesar J, Harris L, Faerber A, Havighurst T, Young JM, Efros M, Getzenberg RH, Wheeler MA, Tangrea J, Parnes H, House M, Busby JE, Hohl R, Bailey H. "A phase 2 cancer chemoprevention biomarker trial of isoflavone G-2535 (genistein) in presurgical bladder cancer patients." Cancer prevention research.. 2012 Apr; 5(4):621-30. Epub 2012 Jan 31.
2/15/2012
Ting HJ, Yasmin-Karim S, Yan SJ, Hsu JW, Lin TH, Zeng W, Messing J, Sheu TJ, Bao BY, Li W, Messing E, Lee YF. "A positive feedback signaling loop between ATM and the vitamin D receptor is critical for cancer chemoprevention by vitamin D." Cancer research.. 2012 Feb 15; 72(4):958-68. Epub 2011 Dec 29.
1/1/2012
Scosyrev E, Messing EM, van Wijngaarden E, Peterson DR, Sahasrabudhe D, Golijanin D, Fisher SG. "Neoadjuvant gemcitabine and cisplatin chemotherapy for locally advanced urothelial cancer of the bladder." Cancer.. 2012 Jan 1; 118(1):72-81. Epub 2011 Jun 30.
1/2012
Scosyrev E, Golijanin D, Wu G, Messing E. "The burden of bladder cancer in men and women: analysis of the years of life lost." BJU international.. 2012 Jan; 109(1):57-62. Epub 2011 Aug 23.
1/2012
Gordetsky J, Scosyrev E, Rashid H, Wu G, Silvers C, Golijanin D, Messing EM, Yao JL. "Identifying additional lymph nodes in radical cystectomy lymphadenectomy specimens." Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.. 2012 Jan; 25(1):140-4. Epub 2011 Sep 09.
2012
Tobis S, Knopf J, Silvers C, Marshall J, Cardin A, Wood R, Reeder J, Erturk E, Madeb R, Yao J, Singer E, Rashid H,
Wu G, Messing E, Golijanin J. "Near infrared fluorescence imaging following intravenous indocyanine green: Initial clinical experience with open partial nephrectomy for renal cortical tumors". Urology. 2012; April 79(4): 958-64.
2012
Tobis S, Venigalla S, Knopf JK, Scosyrev E, Golijanin D, Erturk E, Joseph JV, Rashid H, Wu GJ. "Robot-assisted laparoscopic partial nephrectomy: review of the first 100 cases from a single institution". J Endourology. 2012; July 26(7): 797-802.
2012
Knopf J, Messing E. "Editorial Comment". Urology. 2012; 79(1): 171.
2012
Scosyrev E, Messing J, Noyes K, Veazie P, Messing E. "Surveillance Epidemiology and End Results (SEER) program and population-based research in urologic oncology: an overview." Urologic oncology.. 2012 30(2):126-32. Epub 2010 Apr 03.
2012
Messing EM, Albertsen P, Andriole GL, Carroll PR, Klein EA. "The Society of Urologic Oncology's reply to the US Preventative Services Task Force's recommendation on PSA testing." Urologic oncology.. 2012 30(1):117-9.
9/2011
Scosyrev E, Ely BW, Messing EM, Speights VO, Grossman HB, Wood DP, de Vere White RW, Vogelzang NJ, Trump DL, Natale RB, Tangen CM, Crawford ED, Thompson IM. "Do mixed histological features affect survival benefit from neoadjuvant platinum-based combination chemotherapy in patients with locally advanced bladder cancer? A secondary analysis of Southwest Oncology Group-Directed Intergroup Study (S8710)." BJU international.. 2011 Sep; 108(5):693-9. Epub 2010 Nov 24.
9/2011
Scosyrev E, Messing EM. "Do mixed histological features affect survival benefit from neoadjuvant platinum-based combination chemotherapy in patients with locally advanced bladder cancer?" BJU international.. 2011 Sep; 108(5):700.
8/2011
Gordetsky J, Findeis-Hosey J, Erturk E, Messing EM, Yao JL, Miyamoto H. "Role of frozen section analysis of testicular/paratesticular fibrous pseudotumours: a five-case experience." Canadian Urological Association journal = Journal de l'Association des urologues du Canada.. 2011 Aug; 5(4):E47-51.
7/2011
Purnell JQ, Palesh OG, Heckler CE, Adams MJ, Chin N, Mohile S, Peppone LJ, Atkins JN, Moore DF, Spiegel D, Messing E, Morrow GR. "Racial disparities in traumatic stress in prostate cancer patients: secondary analysis of a National URCC CCOP Study of 317 men." Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer.. 2011 Jul; 19(7):899-907. Epub 2010 Apr 23.
7/2011
Mir C, Shariat SF, Van Der Kwast TH, Ashfaq R, Lotan Y, Evans A, Skeldon S, Hanna S, Vajpeyi R, Kuk C, Alkhateeb S, Morote J, Van Rhijn BW, Bostrom P, Yao J, Miyamoto H, Jewett M, Fleshner N, Messing E, Zlotta AR. "Loss of androgen receptor expression is not associated with pathological stage, grade, gender or outcome in bladder cancer: a large multi-institutional study." BJU international.. 2011 Jul; 108(1):24-30. Epub 2010 Nov 10.
2/3/2011
He X, Wang J, Messing EM, Wu G. "Regulation of receptor for activated C kinase 1 protein by the von Hippel-Lindau tumor suppressor in IGF-I-induced renal carcinoma cell invasiveness." Oncogene.. 2011 Feb 3; 30(5):535-47. Epub 2010 Sep 27.
2/2011
Messing E. "Words of Wisdom. Re: potential impact of postoperative early complications on the timing of adjuvant chemotherapy in patients undergoing radical cystectomy: a high-volume tertiary cancer center experience." European urology.. 2011 Feb; 59(2):302-3.
1/2011
Bendaña EE, Trivedi D, Marshall J, Messing E. "Lost and now found: retained straight catheter for 20 years." Urology.. 2011 Jan; 77(1):73-4. Epub 2010 Apr 09.
2011
Scosyrev E, Wu G, Golijanin D, Messing EM. "Non-bladder cancer mortality in patients with urothelial cancer of the bladder". Urol Oncol. 2011; .
2011
Loberant N, Bhatt S, Messing E, Dogra VS. "Bilateral testicular epidermoid cysts." Journal of clinical imaging science.. 2011 1:4. Epub 2011 Jan 01.
10/2010
Scosyrev E, Yao J, Messing E. "Microscopic invasion of perivesical fat by urothelial carcinoma: implications for prognosis and pathology practice." Urology.. 2010 Oct; 76(4):908-13; discussion 914. Epub 2010 Aug 14.
9/2010
Scosyrev E, Trivedi D, Messing E. "Female bladder cancer: incidence, treatment, and outcome." Current opinion in urology.. 2010 Sep; 20(5):404-8.
9/2010
Messing EM, Golijanin D, Knopf J, Madeb R. "Re: Dipstick pseudohematuria: unnecessary consultation and evaluation. P. K. Rao, T. Gao, M. Pohl and J. S. Jones J Urol 2010; 183: 560-565." The Journal of urology.. 2010 Sep; 184(3):1225; author reply 1225-6. Epub 2010 Jul 31.
5/2010
Bao BY, Ting HJ, Hsu JW, Yasmin-Karim S, Messing E, Lee YF. "Down-regulation of NF-kappaB signals is involved in loss of 1alpha,25-dihydroxyvitamin D3 responsiveness." The Journal of steroid biochemistry and molecular biology.. 2010 May; 120(1):11-21. Epub 2010 Mar 04.
2/2010
Palapattu GS, Singer EA, Messing EM. "Controversies surrounding lymph node dissection for prostate cancer." The Urologic clinics of North America.. 2010 Feb; 37(1):57-65, Table of Contents.
1/2010
Madeb R, Golijanin D, Knopf J, Davis M, Feng C, Fender A, Stephenson L, Messing EM. "Long-term outcome of patients with a negative work-up for asymptomatic microhematuria." Urology.. 2010 Jan; 75(1):20-5. Epub 2009 Nov 13.
2010
Robinson VL, Porter M, Messing E, Fradet Y, Kamat AM, Lotan Y. "BCAN Think Tank session 2: Molecular detection of bladder cancer: the path to progress." Urologic oncology.. 2010 28(3):334-7.
2010
Lerner SP, Grossman HB, Messing EM, Kibel AS, Stephenson A, Gee JR, O'Donnell MA, Reid RD, Kamat AM, Parnes HL, House MG. "BCAN Think Tank session 3: Prevention of bladder cancer." Urologic oncology.. 2010 28(3):338-42.
2010
Kohli M, Rothberg PG, Feng C, Messing E, Joseph J, Rao SS, Hendershot A, Sahsrabudhe D. "Exploratory study of a KLK2 polymorphism as a prognostic marker in prostate cancer." Cancer biomarkers : section A of Disease markers.. 2010 7(2):101-8.
9/10/2009
Trivedi D, Messing EM. "Commentary: the role of cytologic analysis of voided urine in the work-up of asymptomatic microhematuria." BMC urology.. 2009 Sep 10; 9:13. Epub 2009 Sep 10.
9/2009
Yan K, Podder T, Li L, Joseph J, Rubens DR, Messing EM, Liao L, Yu Y. "A real-time prostate cancer detection technique using needle insertion force and patient-specific criteria during percutaneous intervention." Medical physics.. 2009 Sep; 36(9):4184-90.
9/2009
Messing E. "Words of wisdom. Re: Use of 5alpha-reductase inhibitors for prostate cancer chemoprevention: American Society of Clinical Oncology/American Urological Association 2008 clinical practice guideline. Kramer BS, Hagerty KL, Justman S, et al." European urology.. 2009 Sep; 56(3):572.
5/20/2009
Messing EM, Madeb R, Feng C, Stephenson L, Gilchrist KW, Young T, Gee J. "Grade and stage at presentation do not predict mortality in patients with bladder cancer who survive their disease." Journal of clinical oncology : official journal of the American Society of Clinical Oncology.. 2009 May 20; 27(15):2443-9. Epub 2009 Mar 30.
4/2009
Scosyrev E, Yao J, Messing E. "Urothelial carcinoma versus squamous cell carcinoma of bladder: is survival different with stage adjustment?" Urology.. 2009 Apr; 73(4):822-7. Epub 2009 Feb 04.
3/2009
Gee JR, Jarrard DF, Bruskewitz RC, Moon TD, Hedican SP, Leverson GE, Nakada SY, Messing EM. "Reduced bladder cancer recurrence rate with cardioprotective aspirin after intravesical bacille Calmette-Guérin." BJU international.. 2009 Mar; 103(6):736-9. Epub 2008 Oct 31.
3/2009
Thompson IM, Tangen CM, Paradelo J, Lucia MS, Miller G, Troyer D, Messing E, Forman J, Chin J, Swanson G, Canby-Hagino E, Crawford ED. "Adjuvant radiotherapy for pathological T3N0M0 prostate cancer significantly reduces risk of metastases and improves survival: long-term followup of a randomized clinical trial." The Journal of urology.. 2009 Mar; 181(3):956-62. Epub 2009 Jan 23.
1/2009
Chen M, Hsu I, Wolfe A, Radovick S, Huang K, Yu S, Chang C, Messing EM, Yeh S. "Defects of prostate development and reproductive system in the estrogen receptor-alpha null male mice." Endocrinology.. 2009 Jan; 150(1):251-9. Epub 2008 Aug 28.
2009
Madeb R, Golijanin D, Noyes K, Fisher S, Stephenson JJ, Long SR, Knopf J, Lyman G, Messing EM. "Treatment of non-muscle invading bladder cancer: Do physicians in the United States practice evidence based medicine? The use and economic implications of intravesical chemotherapy after transurethral resection of bladder tumors". Cancer. 2009; 115(12):2660-7.
2009
Scosyrev E, Noyes K, Feng CY, Messing EMM. "Sex and racial differences in bladder cancer presentation and mortality in the United States". CANCER. 2009; Jan 1;115(1): 68-74.
2009
Ignatoff JM, Chen YH, Greenberg RE, Pow-Sang JM, Messing EM, Wilding G. "Phase II study of intravesical therapy with AD32 in patients with papillary urothelial carcinoma or carcinoma in situ (CIS) refractory to prior therapy with bacillus Calmette-Guerin (E3897): a trial of the Eastern Cooperative Oncology Group." Urologic oncology.. 2009 27(5):496-501. Epub 2008 Jul 17.
12/2008
Swanson GP, Goldman B, Tangen CM, Chin J, Messing E, Canby-Hagino E, Forman JD, Thompson IM, Crawford ED, . "The prognostic impact of seminal vesicle involvement found at prostatectomy and the effects of adjuvant radiation: data from Southwest Oncology Group 8794." The Journal of urology.. 2008 Dec; 180(6):2453-7; discussion 2458. Epub 2008 Oct 19.
12/2008
Singer EA, Golijanin DJ, Messing EM. "Androgen deprivation therapy for advanced prostate cancer: why does it fail and can its effects be prolonged?" The Canadian journal of urology.. 2008 Dec; 15(6):4381-7.
9/2008
Johnson AM, O'Connell MJ, Messing EM, Reeder JE. "Decreased bladder cancer growth in parous mice." Urology.. 2008 Sep; 72(3):470-3. Epub 2008 Jun 04.
9/2008
Noyes K, Singer EA, Messing EM. "Healthcare economics of bladder cancer: cost-enhancing and cost-reducing factors." Current opinion in urology.. 2008 Sep; 18(5):533-9.
8/26/2008
Niu Y, Altuwaijri S, Lai KP, Wu CT, Ricke WA, Messing EM, Yao J, Yeh S, Chang C. "Androgen receptor is a tumor suppressor and proliferator in prostate cancer." Proceedings of the National Academy of Sciences of the United States of America.. 2008 Aug 26; 105(34):12182-7. Epub 2008 Aug 22.
7/2008
Zhang M, Nigwekar P, Castaneda B, Hoyt K, Joseph JV, di Sant'Agnese A, Messing EM, Strang JG, Rubens DJ, Parker KJ. "Quantitative characterization of viscoelastic properties of human prostate correlated with histology." Ultrasound in medicine & biology.. 2008 Jul; 34(7):1033-42. Epub 2008 Feb 06.
4/23/2008
Johnson AM, O'Connell MJ, Miyamoto H, Huang J, Yao JL, Messing EM, Reeder JE. "Androgenic dependence of exophytic tumor growth in a transgenic mouse model of bladder cancer: a role for thrombospondin-1." BMC urology.. 2008 Apr 23; 8:7. Epub 2008 Apr 23.
3/21/2008
Podder T, Sherman J, Rubens D, Messing E, Strang J, Ng WS, Yu Y. "Methods for prostate stabilization during transperineal LDR brachytherapy." Physics in medicine and biology.. 2008 Mar 21; 53(6):1563-79. Epub 2008 Feb 22.
3/2008
Messing EM. "Why should we increase public awareness of bladder cancer, and how can we do it?" Nature clinical practice. Urology.. 2008 Mar; 5(3):117.
2008
Messing EM, Madeb RM. "Long-term outcome of dip-stick testing for hematuria". World Journal of Urology. 2008; 26(1): 19-24.
11/2007
Yu Y, Podder TK, Zhang YD, Ng WS, Misic V, Sherman J, Fuller D, Rubens DJ, Strang JG, Brasacchio RA, Messing EM. "Robotic system for prostate brachytherapy." Computer aided surgery : official journal of the International
Society for Computer Aided Surgery. 2007 Nov; 12(6):366-70.
9/2007
Ting HJ, Bao BY, Reeder JE, Messing EM, Lee YF. "Increased expression of corepressors in aggressive androgen-independent prostate cancer cells results in loss of 1alpha,25-dihydroxyvitamin D3 responsiveness." Molecular cancer research : MCR.. 2007 Sep; 5(9):967-80.
7/2007
Madeb R, Golijanin D, Knopf J, Messing EM. "Current state of screening for bladder cancer." Expert review of anticancer therapy.. 2007 Jul; 7(7):981-7.
6/1/2007
Swanson GP, Hussey MA, Tangen CM, Chin J, Messing E, Canby-Hagino E, Forman JD, Thompson IM, Crawford ED, . "Predominant treatment failure in postprostatectomy patients is local: analysis of patterns of treatment failure in SWOG 8794." Journal of clinical oncology : official journal of the American Society of Clinical Oncology.. 2007 Jun 1; 25(16):2225-9.
4/4/2007
Miyamoto H, Yang Z, Chen YT, Ishiguro H, Uemura H, Kubota Y, Nagashima Y, Chang YJ, Hu YC, Tsai MY, Yeh S, Messing EM, Chang C. "Promotion of bladder cancer development and progression by androgen receptor signals." Journal of the National Cancer Institute.. 2007 Apr 4; 99(7):558-68.
2007
Podder TK, Sherman J, L Li, Joseph J, Ruben DR, Messing EM, Huang J, Yu Y. "Mechanical properties of human prostate tissue in the context of surgical needle insertions". International Journal of Computer Assisted Radiology and Surgery. 2007; 2007;S106-108.
2007
Messing, EM. "Microhematuria: Implications of an unexpected finding". Consultant. 2007; 47: 356.
11/15/2006
Thompson IM, Tangen CM, Paradelo J, Lucia MS, Miller G, Troyer D, Messing E, Forman J, Chin J, Swanson G, Canby-Hagino E, Crawford ED. "Adjuvant radiotherapy for pathologically advanced prostate cancer: a randomized clinical trial." JAMA.. 2006 Nov 15; 296(19):2329-35.
11/1/2006
Messing EM, Madeb R, Young T, Gilchrist KW, Bram L, Greenberg EB, Wegenke JD, Stephenson L, Gee J, Feng C. "Long-term outcome of hematuria home screening for bladder cancer in men." Cancer.. 2006 Nov 1; 107(9):2173-9.
11/2006
Golijanin DJ, Kakiashvili D, Madeb RR, Messing EM, Lerner SP. "Chemoprevention of bladder cancer." World journal of urology.. 2006 Nov; 24(5):445-72.
8/2006
Messing E, Kim KM, Sharkey F, Schultz M, Parnes H, Kim D, Saltzstein D, Wilding G. "Randomized prospective phase III trial of difluoromethylornithine vs placebo in preventing recurrence of completely resected low risk superficial bladder cancer." The Journal of urology.. 2006 Aug; 176(2):500-4.
8/2006
Podder T, Clark D, Sherman J, Fuller D, Messing E, Rubens D, Strang J, Brasacchio R, Liao L, Ng WS, Yu Y. "Vivo motion and force measurement of surgical needle intervention during prostate brachytherapy." Medical physics.. 2006 Aug; 33(8):2915-22.
6/2006
Messing EM, Manola J, Yao J, Kiernan M, Crawford D, Wilding G, di'SantAgnese PA, Trump D, . "Immediate versus deferred androgen deprivation treatment in patients with node-positive prostate cancer after radical prostatectomy and pelvic lymphadenectomy." The Lancet. Oncology.. 2006 Jun; 7(6):472-9.
6/2006
Johnson AM, Conover DL, Huang J, Messing EM, Ning R, O'Connell MJ, Rossi MA, Sun TT, Wood RW, Wu XR, Reeder JE. "Early detection and measurement of urothelial tumors in mice." Urology.. 2006 Jun; 67(6):1309-14.
6/2006
Wood RW, Baggs RB, Schwarz EM, Messing EM. "Initial observations of reduced uroflow in transgenic adenocarcinoma of murine prostate." Urology.. 2006 Jun; 67(6):1324-8.
5/2006
Palapattu GS, Messing EM. "Do prostate cancer patients at risk of pelvic lymph-node metastasis benefit from pelvic radiation?" Nature clinical practice. Urology.. 2006 May; 3(5):258-9.
5/2006
Fu L, Liu H, Ng WS, Rubens D, Strang J, Messing E, Yu Y. "Hybrid dosimetry: feasibility of mixing angulated and parallel needles in planning prostate brachytherapy." Medical physics.. 2006 May; 33(5):1192-8.
4/2006
Messing EM. "Bladder tumor markers." The Journal of urology.. 2006 Apr; 175(4):1195-6.
1/18/2006
Grossman HB, Soloway M, Messing E, Katz G, Stein B, Kassabian V, Shen Y. "Surveillance for recurrent bladder cancer using a point-of-care proteomic assay." JAMA.. 2006 Jan 18; 295(3):299-305.
2006
Boczko J, Messing EM, Dogra V. "Prostate sonography". Radiology Clin N Am. 2006; 44(4).
2006
V. Misic, L. Fu, T.K. Podder, L. Liao, D.J. Rubens, R. Brasacchio, E.M. Messing, J.G. Strang, W.S. Ng, and Y. Yu. "Dynamic planning in single needle brachytherapy systems". Int. J. CARS. 2006; 1 (265) 271 – 273.
2006
T.K. Podder, L. Liao, J. Sherman, D. Fuller, V. Misic, D.J. Rubens, E.M. Messing, J.G. Strang, W.S. Ng, and Y. Yu. "A method to minimize puncture force and organ deformation". Int. J. CARS. 2006; 1(265) 277 – 280.
2006
Podder TK, Sherman J, Messing EM, Rubens DJ, Fuller D, Strang JG, Brasacchio RA, Yu Y. "Needle insertion force estimation model using procedure-specific and patient-specific criteria." Conference proceedings : ... Annual International Conference of the IEEE Engineering in Medicine and Biology Society.. 2006 1:555-8.
2006
Sherman J, Podder TK, Misic V, Fu L, Fuller D, Winey B, Messing EM, Rubens DJ, Strang JG, Brasacchio R, Yu Y. "Efficacy of prostate stabilizing techniques during brachytherapy procedure." Conference proceedings : ... Annual International Conference of the IEEE Engineering in Medicine and Biology Society.. 2006 1:563-6.
2006
Podder TK, Sherman J, Fuller D, Messing EM, Rubens DJ, Strang JG, Brasacchio RA, Yu Y. "In-vivo measurement of surgical needle intervention parameters: a pilot study." Conference proceedings : ... Annual International Conference of the IEEE Engineering in Medicine and Biology Society.. 2006 1:3652-5.
12/2005
Taylor LS, Rubens DJ, Porter BC, Wu Z, Baggs RB, di Sant'Agnese PA, Nadasdy G, Pasternack D, Messing EM, Nigwekar P, Parker KJ. "Prostate cancer: three-dimensional sonoelastography for in vitro detection." Radiology.. 2005 Dec; 237(3):981-5. Epub 2005 Oct 26.
12/2005
Lokeshwar VB, Habuchi T, Grossman HB, Murphy WM, Hautmann SH, Hemstreet GP, Bono AV, Getzenberg RH, Goebell P, Schmitz-Dräger BJ, Schalken JA, Fradet Y, Marberger M, Messing E, Droller MJ. "Bladder tumor markers beyond cytology: International Consensus Panel on bladder tumor markers." Urology.. 2005 Dec; 66(6 Suppl 1):35-63.
11/1/2005
Ni J, Wen X, Yao J, Chang HC, Yin Y, Zhang M, Xie S, Chen M, Simons B, Chang P, di Sant'Agnese A, Messing EM, Yeh S. "Tocopherol-associated protein suppresses prostate cancer cell growth by inhibition of the phosphoinositide 3-kinase pathway." Cancer research.. 2005 Nov 1; 65(21):9807-16.
10/2005
Messing EM, Teot L, Korman H, Underhill E, Barker E, Stork B, Qian J, Bostwick DG. "Performance of urine test in patients monitored for recurrence of bladder cancer: a multicenter study in the United States." The Journal of urology.. 2005 Oct; 174(4 Pt 1):1238-41.
9/2005
Miyamoto H, Altuwaijri S, Cai Y, Messing EM, Chang C. "Inhibition of the Akt, cyclooxygenase-2, and matrix metalloproteinase-9 pathways in combination with androgen deprivation therapy: potential therapeutic approaches for prostate cancer." Molecular carcinogenesis.. 2005 Sep; 44(1):1-10.
5/2005
Miyamoto H, Messing EM, Chang C. "Does androgen deprivation improve treatment outcomes in patients with low-risk and intermediate-risk prostate cancer?" Nature clinical practice. Oncology.. 2005 May; 2(5):236-7.
4/22/2005
Wang D, Li Z, Messing EM, Wu G. "The SPRY domain-containing SOCS box protein 1 (SSB-1) interacts with MET and enhances the hepatocyte growth factor-induced Erk-Elk-1-serum response element pathway." The Journal of biological chemistry.. 2005 Apr 22; 280(16):16393-401. Epub 2005 Feb 15.
4/2005
Mayer R, Propert KJ, Peters KM, Payne CK, Zhang Y, Burks D, Culkin DJ, Diokno A, Hanno P, Landis JR, Madigan R, Messing EM, Nickel JC, Sant GR, Warren J, Wein AJ, Kusek JW, Nyberg LM, Foster HE, . "A randomized controlled trial of intravesical bacillus calmette-guerin for treatment refractory interstitial cystitis." The Journal of urology.. 2005 Apr; 173(4):1186-91.
4/2005
Li Z, Wang D, Messing EM, Wu G. "VHL protein-interacting deubiquitinating enzyme 2 deubiquitinates and stabilizes HIF-1alpha." EMBO reports.. 2005 Apr; 6(4):373-8.
2/16/2005
Grossman HB, Messing E, Soloway M, Tomera K, Katz G, Berger Y, Shen Y. "Detection of bladder cancer using a point-of-care proteomic assay." JAMA.. 2005 Feb 16; 293(7):810-6.
2005
Podder TK, Sherman J, Clark DP, Messing EM, Rubens DJ, Strang JG, Liao L, Ng WS, Zhang YD, Yu Y. "Method to reduce force and target movement during surgical needle interventions". European Medical & Biol Engineer. 2005; 11:4315-4320.
2005
Podder TK, Clark DP, Fuller D, Messing EM, Rubens DJ, Strang JG, O'Dell W, Zhang YD, Ng WS, Yu Y. "Effects of tip geometry of surgical needles: An assessment of force-torque and deflection". European Medical & Biol Engineer. 2005; 11:1641-1644.
2005
Habuchi, T., Marberger, M., Droller, M.J., Hemstreet III, G.P., Grossman, H.B., Schalken, J.A., Schmitz-Drager, B. J., Murphy, W.M., Bono, A.V., Goebell, P., Getzenberg, R.H., Hautmann, S.H., Messing, E., Fradet, Y., Lokeshwar, V.B. "Prognostic marker for bladder cancer: Bladder Cancer Consensus Panel". Urology. 2005; 66:64-74.
2005
Fu L, Ng WS, Liu H, O'Dell W, Rubens D, Strang J, Schell MC, Brasacchio R, Liao L, Messing E, Yu Y. "Bouquet brachytherapy: feasibility and optimization of conically spaced implants." Brachytherapy.. 2005 4(1):59-63.
2005
Podder TK, Clark DP, Fuller D, Sherman J, Ng WS, Liao L, Rubens DJ, Strang JG, Messing EM, Zhang YD, Yu Y. "Effects of velocity modulation during surgical needle insertion." Conference proceedings : ... Annual International Conference of the IEEE Engineering in Medicine and Biology Society.. 2005 6:5766-70.
12/1/2004
Miyamoto H, Messing EM, Chang C. "Androgen deprivation therapy for prostate cancer: current status and future prospects." The Prostate.. 2004 Dec 1; 61(4):332-53.
8/2004
Leung YY, Schwarz EM, Silvers CR, Messing EM, Wood RW. "Uroflow in murine urethritis." Urology.. 2004 Aug; 64(2):378-82.
6/2004
Miyamoto H, Messing EM. "Early versus late hormonal therapy for prostate cancer." Current urology reports.. 2004 Jun; 5(3):188-96.
4/6/2004
Rashid HH, Reeder JE, O'Connell MJ, Zhang CO, Messing EM, Keay SK. "Interstitial cystitis antiproliferative factor (APF) as a cell-cycle modulator." BMC urology.. 2004 Apr 6; 4:3. Epub 2004 Apr 06.
1/9/2004
Wang D, Li Z, Schoen SR, Messing EM, Wu G. "A novel MET-interacting protein shares high sequence similarity with RanBPM, but fails to stimulate MET-induced Ras/Erk signaling." Biochemical and biophysical research communications.. 2004 Jan 9; 313(2):320-6.
1/8/2004
Wright KO, Messing EM, Reeder JE. "DBCCR1 mediates death in cultured bladder tumor cells." Oncogene.. 2004 Jan 8; 23(1):82-90.
1/1/2004
Singh D, Yi WS, Brasacchio RA, Muhs AG, Smudzin T, Williams JP, Messing E, Okunieff P. "Is there a favorable subset of patients with prostate cancer who develop oligometastases?" International journal of radiation oncology, biology, physics.. 2004 Jan 1; 58(1):3-10.
2004
Madeb R, Messing EM. "Gender, racial and age differences in bladder cancer incidence and mortality." Urologic oncology.. 2004 22(2):86-92.
2004
Rashid HH, Cos LR, Weinberg E, Messing EM. "Testicular microlithiasis: a review and its association with testicular cancer." Urologic oncology.. 2004 22(4):285-9.
11/2003
Messing EM, Thompson I. "Follow-up of conservatively managed prostate cancer: watchful waiting and primary hormonal therapy." The Urologic clinics of North America.. 2003 Nov; 30(4):687-702, viii.
9/2003
Sant GR, Propert KJ, Hanno PM, Burks D, Culkin D, Diokno AC, Hardy C, Landis JR, Mayer R, Madigan R, Messing EM, Peters K, Theoharides TC, Warren J, Wein AJ, Steers W, Kusek JW, Nyberg LM, . "A pilot clinical trial of oral pentosan polysulfate and oral hydroxyzine in patients with interstitial cystitis." The Journal of urology.. 2003 Sep; 170(3):810-5.
8/15/2003
Na X, Duan HO, Messing EM, Schoen SR, Ryan CK, di Sant'Agnese PA, Golemis EA, Wu G. "Identification of the RNA polymerase II subunit hsRPB7 as a novel target of the von Hippel-Lindau protein." The EMBO journal.. 2003 Aug 15; 22(16):4249-59.
8/2003
Na X, Wu G, Ryan CK, Schoen SR, di'Santagnese PA, Messing EM. "Overproduction of vascular endothelial growth factor related to von Hippel-Lindau tumor suppressor gene mutations and hypoxia-inducible factor-1 alpha expression in renal cell carcinomas." The Journal of urology.. 2003 Aug; 170(2 Pt 1):588-92.
7/23/2003
Reeder JE, Sowden MP, Messing EM, Klover P, Villa-Moruzzi E, Ludlow JW. "Inducible expression of catalytically active type 1 serine/threonine protein phosphatase in a human carcinoma cell line." Cancer cell international.. 2003 Jul 23; 3(1):12. Epub 2003 Jul 23.
6/2003
Borhan A, Reeder JE, O'Connell MJ, Wright KO, Wheeless LL, di Sant'Agnese PA, McNally ML, Messing EM. "Grade progression and regression in recurrent urothelial cancer." The Journal of urology.. 2003 Jun; 169(6):2106-9.
5/7/2003
Liu H, Cheng G, Yu Y, Brasacchio R, Rubens D, Strang J, Liao L, Messing E. "Automatic localization of implanted seeds from post-implant CT images." Physics in medicine and biology.. 2003 May 7; 48(9):1191-203.
4/15/2003
Li Z, Wang D, Na X, Schoen SR, Messing EM, Wu G. "The VHL protein recruits a novel KRAB-A domain protein to repress HIF-1alpha transcriptional activity." The EMBO journal.. 2003 Apr 15; 22(8):1857-67.
4/1/2003
Messing EM, Manola J, Wilding G, Propert K, Fleischmann J, Crawford ED, Pontes JE, Hahn R, Trump D, . "Phase III study of interferon alfa-NL as adjuvant treatment for resectable renal cell carcinoma: an Eastern Cooperative Oncology Group/Intergroup trial." Journal of clinical oncology : official journal of the American Society of Clinical Oncology.. 2003 Apr 1; 21(7):1214-22.
12/2002
Wright KO, Messing EM, Reeder JE. "Increased expression of the acid sphingomyelinase-like protein ASML3a in bladder tumors." The Journal of urology.. 2002 Dec; 168(6):2645-9.
11/1/2002
Lee YF, Lin WJ, Huang J, Messing EM, Chan FL, Wilding G, Chang C. "Activation of mitogen-activated protein kinase pathway by the antiandrogen hydroxyflutamide in androgen receptor-negative prostate cancer cells." Cancer research.. 2002 Nov 1; 62(21):6039-44.
11/2002
Gottlieb RH, La TC, Erturk EN, Sotack JL, Voci SL, Holloway RG, Syed L, Mikityansky I, Tirkes AT, Elmarzouky R, Zwemer FL, Joseph JV, Davis D, DiGrazio WJ, Messing EM. "CT in detecting urinary tract calculi: influence on patient imaging and clinical outcomes." Radiology.. 2002 Nov; 225(2):441-9.
10/2002
Sessions A, Eichel L, Kassahun M, Messing EM, Schwarz E, Wood RW. "Continuous bladder infusion methods for studying voiding function in the ambulatory mouse." Urology.. 2002 Oct; 60(4):707-13.
9/27/2002
Wang D, Li Z, Messing EM, Wu G. "Activation of Ras/Erk pathway by a novel MET-interacting protein RanBPM." The Journal of biological chemistry.. 2002 Sep 27; 277(39):36216-22. Epub 2002 Jul 29.
6/14/2002
Li Z, Wang D, Na X, Schoen SR, Messing EM, Wu G. "Identification of a deubiquitinating enzyme subfamily as substrates of the von Hippel-Lindau tumor suppressor." Biochemical and biophysical research communications.. 2002 Jun 14; 294(3):700-9.
5/28/2002
Zhang Y, Ni J, Messing EM, Chang E, Yang CR, Yeh S. "Vitamin E succinate inhibits the function of androgen receptor and the expression of prostate-specific antigen in prostate cancer cells." Proceedings of the National Academy of Sciences of the United States of America.. 2002 May 28; 99(11):7408-13.
5/15/2002
Fisher TL, Nocera M, Willis RA, Turner MJ, Abdul Alim CS, Brown DM, Bourne PA, di Sant'Agnese PA, Messing EM, Lord EM, Frelinger JG. "Generation of monoclonal antibodies specific for human kallikrein 2 (hK2) using hK2-expressing tumors." The Prostate.. 2002 May 15; 51(3):153-65.
2/15/2002
Li Z, Na X, Wang D, Schoen SR, Messing EM, Wu G. "Ubiquitination of a novel deubiquitinating enzyme requires direct binding to von Hippel-Lindau tumor suppressor protein." The Journal of biological chemistry.. 2002 Feb 15; 277(7):4656-62. Epub 2001 Dec 05.
2/2002
Sessions AE, Messing EM. "Timing hormonal therapy in prostate cancer." The Urologic clinics of North America.. 2002 Feb; 29(1):223-7, xi.
8/2001
Brawer MK, Stamey TA, Fowler J, Droller M, Messing E, Fair WR. "Perspectives on prostate cancer diagnosis and treatment: a roundtable." Urology.. 2001 Aug; 58(2):135-40.
7/2001
Eichel L, Scheidweiler K, Kost J, Shojaie J, Schwarz E, Messing E, Wood R. "Assessment of murine bladder permeability with fluorescein: validation with cyclophosphamide and protamine." Urology.. 2001 Jul; 58(1):113-8.
6/2001
Eichel LS, Sessions AE, Messing EM, Schwarz E, Wood RW. "Continuous bladder infusion methods for studying voiding function in ambulatory mice." Urology.. 2001 Jun; 57(6 Suppl 1):115.
6/2001
Eichel L, Scheidweiler K, Kost J, Shojaie J, Schwarz E, Messing EM, Wood R. "Assessment of murine bladder permeability with fluorescein: validation with cyclophosphamide and protamine." Urology.. 2001 Jun; 57(6 Suppl 1):115.
6/2001
Wood R, Pittelli R, Foster D, Mayer R, Messing EM. "Human bladder permeability assessment using intravesical fluorescein clearance rate." Urology.. 2001 Jun; 57(6 Suppl 1):131-2.
5/2001
Strang JG, Rubens DJ, Brasacchio RA, Yu Y, Messing EM. "Real-time US versus CT determination of pubic arch interference for brachytherapy." Radiology.. 2001 May; 219(2):387-93.
3/2001
Mantalaris A, Panoskaltsis N, Sakai Y, Bourne P, Chang C, Messing EM, Wu JH. "Localization of androgen receptor expression in human bone marrow." The Journal of pathology.. 2001 Mar; 193(3):361-6.
2/2001
Wood R, Eichel L, Messing EM, Schwarz E. "Automated noninvasive measurement of cyclophosphamide-induced changes in murine voiding frequency and volume." The Journal of urology.. 2001 Feb; 165(2):653-9.
11/1/2000
Messing EM. "Editorial comment" Urology.. 2000 Nov 1; 56(5):791-2.
5/2000
deVere White RW, Deitch AD, Daneshmand S, Blumenstein B, Lowe BA, Sagalowsky AI, Smith JA, Schellhammer PF, Stanisic TH, Grossman HB, Messing E, Crissman JD, Crawford ED. "The prognostic significance of S-phase analysis in stage Ta/T1 bladder cancer. A Southwest Oncology Group Study." European urology.. 2000 May; 37(5):595-600.
2000
Messing, EM. "Early hormonal therapy in prostate cancer (Editorial)". NEJM. 2000; 342:1216.
2000
Jung I, Messing E. "Molecular mechanisms and pathways in bladder cancer development and progression." Cancer control : journal of the Moffitt Cancer Center.. 2000 7(4):325-34.
12/9/1999
Messing EM, Manola J, Sarosdy M, Wilding G, Crawford ED, Trump D. "Immediate hormonal therapy compared with observation after radical prostatectomy and pelvic lymphadenectomy in men with node-positive prostate cancer." The New England journal of medicine.. 1999 Dec 9; 341(24):1781-8.
12/1999
Jung I, Reeder JE, Cox C, Siddiqui JF, O'Connell MJ, Collins L, Yang Z, Messing EM, Wheeless LL. "Chromosome 9 monosomy by fluorescence in situ hybridization of bladder irrigation specimens is predictive of tumor recurrence." The Journal of urology.. 1999 Dec; 162(6):1900-3.
8/18/1999
Messing EM, Love RR, Tutsch KD, Verma AK, Douglas J, Pomplun M, Simsiman R, Wilding G. "Low-dose difluoromethylornithine and polyamine levels in human prostate tissue." Journal of the National Cancer Institute.. 1999 Aug 18; 91(16):1416-7.
7/1/1999
Messing EM, Zhang JB, Rubens DJ, Brasacchio RA, Strang JG, Soni A, Schell MC, Okunieff PG, Yu Y. "Intraoperative optimized inverse planning for prostate brachytherapy: early experience." International journal of radiation oncology, biology, physics.. 1999 Jul 1; 44(4):801-8.
7/1999
Gottlieb RH, Zusman E, Hartley DF, Rubens DJ, Voci SL, Robinette W, Melendez L, Morris TW, Ojha S, Chengazi V, Erturk E, Messing EM. "Effect of angiotensin converting enzyme inhibition on the Doppler waveform in dogs with renal artery stenosis." Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.. 1999 Jul; 18(7):481-7.
6/1999
Messing EM. "Interstitial cystitis--a light at the end of the tunnel?" The Journal of urology.. 1999 Jun; 161(6):1797.
2/1/1999
Yu Y, Zhang JB, Brasacchio RA, Okunieff PG, Rubens DJ, Strang JG, Soni A, Messing EM. "Automated treatment planning engine for prostate seed implant brachytherapy." International journal of radiation oncology, biology, physics.. 1999 Feb 1; 43(3):647-52.
1999
Ochal LK, Sowden MP, Messing EM, Wheeless LL, Reeder JE. "Mus musculus DBCCR1 mRNA, complete sequence". GenBank Accession. 1999; AF202896.
9/15/1998
Miyamoto H, Yeh S, Lardy H, Messing E, Chang C. "Delta5-androstenediol is a natural hormone with androgenic activity in human prostate cancer cells." Proceedings of the National Academy of Sciences of the United States of America.. 1998 Sep 15; 95(19):11083-8.
8/1998
Pan HJ, Wilding G, Uno H, Inui S, Goldsmith L, Messing E, Chang C. "Evaluation of RU58841 as an anti-androgen in prostate PC3 cells and a topical anti-alopecia agent in the bald scalp of stumptailed macaques." Endocrine.. 1998 Aug; 9(1):39-43.
5/1998
Reeder JE, O'Connell MJ, Yang Z, Morreale JF, Collins L, Frank IN, Messing EM, Cockett AT, Cox C, Robinson RD, Wheeless LL. "DNA cytometry and chromosome 9 aberrations by fluorescence in situ hybridization of irrigation specimens from bladder cancer patients." Urology.. 1998 May; 51(5A Suppl):58-61.
3/1998
Jepsen JV, Sall M, Rhodes PR, Schmidt D, Messing E, Bruskewitz RC. "Long-term experience with pentosanpolysulfate in interstitial cystitis." Urology.. 1998 Mar; 51(3):381-7.
2/15/1998
Stewart J, Kozlowski P, Sowden M, Messing E, Smith HC. "A quantitative assay for assessing allelic proportions by iterative gap ligation." Nucleic acids research.. 1998 Feb 15; 26(4):961-6.
1/1998
Goldstein MM, Messing EM. "Prostate and bladder cancer screening." Journal of the American College of Surgeons.. 1998 Jan; 186(1):63-74.
1998
Yu Y, Zhang JB, Brasacchio R, Okunieff P, Rubens D, Strang J, Soni A, Messing E. "Automated Treatment Planning Engine for Prostate Seed Implant Brachytherapy". Int J Rad Onc. 1998; 43:1-7.
11/1997
Reeder JE, Morreale JF, O'Connell MJ, Stadler WM, Olopade OF, Messing EM, Wheeless LL. "Loss of the CDKN2A/p16 locus detected in bladder irrigation specimens by fluorescence in situ hybridization." The Journal of urology.. 1997 Nov; 158(5):1717-21.
10/1997
Buzzeo BD, Heisey DM, Messing EM. "Bladder cancer in renal transplant recipients." Urology.. 1997 Oct; 50(4):525-8.
5/1997
Messing E, Pauk D, Schaeffer A, Nieweglowski M, Nyberg LM, Landis JR, Cook YL, Simon LJ. "Associations among cystoscopic findings and symptoms and physical examination findings in women enrolled in the Interstitial Cystitis Data Base (ICDB) Study." Urology.. 1997 May; 49(5A Suppl):81-5.
4/1997
Sall M, Madsen FA, Rhodes PR, Jønler M, Messing EM, Bruskewitz RC. "Pelvic pain following radical retropubic prostatectomy: a prospective study." Urology.. 1997 Apr; 49(4):575-9.
3/1997
Joseph JV, Messing M. "Chemoprevention of Bladder and Prostate Carcinoma." Cancer control : journal of the Moffitt Cancer Center.. 1997 Mar; 4(2):136-141.
1997
Kozlowski P, Messing EM. "Bladder Cancer Screening". Family Urology. 1997; : 16-18.
1997
Foresman WH, Messing EM. "Bladder cancer: natural history, tumor markers, and early detection strategies." Seminars in surgical oncology.. 1997 13(5):299-306.
10/1996
Carpinito GA, Stadler WM, Briggman JV, Chodak GW, Church PA, Lamm DL, Lange PH, Messing EM, Pasciak RM, Reservitz GB, Ross RN, Rukstalis DB, Sarosdy MF, Soloway MS, Thiel RP, Vogelzang N, Hayden CL. "Urinary nuclear matrix protein as a marker for transitional cell carcinoma of the urinary tract." The Journal of urology.. 1996 Oct; 156(4):1280-5.
9/1996
Jønler M, Madsen FA, Rhodes PR, Sall M, Messing EM, Bruskewitz RC. "A prospective study of quantification of urinary incontinence and quality of life in patients undergoing radical retropubic prostatectomy." Urology.. 1996 Sep; 48(3):433-40.
5/1996
Loprinzi CL, Messing EM, O'Fallon JR, Poon MA, Love RR, Quella SK, Trump DL, Morton RF, Novotny P. "Toxicity evaluation of difluoromethylornithine: doses for chemoprevention trials." Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.. 1996 May; 5(5):371-4.
3/15/1996
Wu SQ, Hafez GR, Xing W, Newton M, Chen XR, Messing E. "The correlation between the loss of chromosome 14q with histologic tumor grade, pathologic stage, and outcome of patients with nonpapillary renal cell carcinoma." Cancer.. 1996 Mar 15; 77(6):1154-60.
9/1995
D'Alessandro AM, Sollinger HW, Knechtle SJ, Kalayoglu M, Kisken WA, Uehling DT, Moon TD, Messing EM, Bruskewitz RC, Pirsch JD. "Living related and unrelated donors for kidney transplantation. A 28-year experience." Annals of surgery.. 1995 Sep; 222(3):353-62; discussion 362-4.
8/1995
Howard SP, Groch KM, Lindstrom MJ, Messing EM, Gould MN. "Proliferation-independent growth factor modulation of the radiation sensitivity of human prostate cells." Radiation research.. 1995 Aug; 143(2):229-33.
7/1995
Messing EM, Young TB, Hunt VB, Newton MA, Bram LL, Vaillancourt A, Hisgen WJ, Greenberg EB, Kuglitsch ME, Wegenke JD. "Hematuria home screening: repeat testing results." The Journal of urology.. 1995 Jul; 154(1):57-61.
7/1995
Glazier DB, Bahnson RR, McLeod DG, von Roemeling RW, Messing EM, Ernstoff MS. "Intravesical recombinant tumor necrosis factor in the treatment of superficial bladder cancer: an Eastern Cooperative Oncology Group study." The Journal of urology.. 1995 Jul; 154(1):66-8.
6/1995
Tomic S, Warner TF, Messing E, Wilding G. "Penile Merkel cell carcinoma." Urology.. 1995 Jun; 45(6):1062-5.
3/1995
Messing EM, Young TB, Hunt VB, Gilchrist KW, Newton MA, Bram LL, Hisgen WJ, Greenberg EB, Kuglitsch ME, Wegenke JD. "Comparison of bladder cancer outcome in men undergoing hematuria home screening versus those with standard clinical presentations." Urology.. 1995 Mar; 45(3):387-96; discussion 396-7.
1/1995
Goldberg MR, Heimbrook DC, Russo P, Sarosdy MF, Greenberg RE, Giantonio BJ, Linehan WM, Walther M, Fisher HA, Messing E. "Phase I clinical study of the recombinant oncotoxin TP40 in superficial bladder cancer." Clinical cancer research : an official journal of the American Association for Cancer Research.. 1995 Jan; 1(1):57-61.
1995
Lawrence WF, Bram LL, Messing EM. "The Cost-Effectiveness of Screening Men for Bladder Cancer Using Chemical Reagent Strips to Detect Microscopic Hematuria". J Urology. 1995; 153: 477.
1995
Lamm DL, Blumenstein BA, David Crawford E, Crissman JD, Lowe BA, Smith JA, Sarosdy MF, Schellhammer PF, Sagalowsky AI, Messing EM, Loehrer P, Barton Grossman H. "Randomized intergroup comparison of bacillus calmette-guerin immunotherapy and mitomycin C chemotherapy prophylaxis in superficial transitional cell carcinoma of the bladder a southwest oncology group study." Urologic oncology.. 1995 1(3):119-26.
12/1994
Jønler M, Ritter MA, Brinkmann R, Messing EM, Rhodes PR, Bruskewitz RC. "Sequelae of definitive radiation therapy for prostate cancer localized to the pelvis." Urology.. 1994 Dec; 44(6):876-82.
12/1994
Kloth MT, Gee RL, Messing EM, Swaminathan S. "Expression of N-acetyltransferase (NAT) in cultured human uroepithelial cells." Carcinogenesis.. 1994 Dec; 15(12):2781-7.
10/1994
Messing EM, Murphy-Brooks N. "Recovery of epidermal growth factor in voided urine of patients with bladder cancer." Urology.. 1994 Oct; 44(4):502-6.
9/1994
Jønler M, Messing EM, Rhodes PR, Bruskewitz RC. "Sequelae of radical prostatectomy." British journal of urology. 1994 Sep; 74(3):352-8.
2/1994
Messing EM. "Interstitial cystitis." The Journal of urology.. 1994 Feb; 151(2):355-6.
1994
Frederickson SM, Messing EM, Reznikoff CA, Swaminathan S. "Relationship between in vivo acetylator phenotypes and cytosolic N-acetyltransferase and O-acetyltransferase activities in human uroepithelial cells." Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.. 1994 3(1):25-32.
10/1993
Sollinger HW, Messing EM, Eckhoff DE, Pirsch JD, D'Alessandro AM, Kalayoglu M, Knechtle SJ, Hickey D, Belzer FO. "Urological complications in 210 consecutive simultaneous pancreas-kidney transplants with bladder drainage." Annals of surgery.. 1993 Oct; 218(4):561-8; discussion 568-70.
7/1993
Waples MJ, Messing EM. "Redo retroperitoneal lymphadenectomy for germ cell tumor." Urology.. 1993 Jul; 42(1):31-4.
6/1993
Reznikoff CA, Kao C, Messing EM, Newton M, Swaminathan S. "A molecular genetic model of human bladder carcinogenesis." Seminars in cancer biology.. 1993 Jun; 4(3):143-52.
1/1993
Phillips E, Messing EM. "Role of lymphadenectomy in the treatment of renal cell carcinoma." Urology.. 1993 Jan; 41(1):9-15.
11/1992
Sidransky D, Messing E. "Molecular genetics and biochemical mechanisms in bladder cancer. Oncogenes, tumor suppressor genes, and growth factors." The Urologic clinics of North America.. 1992 Nov; 19(4):629-39.
8/1992
Ritter MA, Messing EM, Shanahan TG, Potts S, Chappell RJ, Kinsella TJ. "Prostate-specific antigen as a predictor of radiotherapy response and patterns of failure in localized prostate cancer." Journal of clinical oncology : official journal of the American Society of Clinical Oncology.. 1992 Aug; 10(8):1208-17.
8/1992
Messing EM, Young TB, Hunt VB, Roecker EB, Vaillancourt AM, Hisgen WJ, Greenberg EB, Kuglitsch ME, Wegenke JD. "Home screening for hematuria: results of a multiclinic study." The Journal of urology.. 1992 Aug; 148(2 Pt 1):289-92.
3/15/1992
Briggs NC, Young TB, Gilchrist KW, Vaillancourt AM, Messing EM. "Age as a predictor of an aggressive clinical course for superficial bladder cancer in men." Cancer.. 1992 Mar 15; 69(6):1445-51.
1992
Loprinzi CL, Messing EM. "A prospective clinical trial of difluoromethylornithine (DFMO) in patients with resected superficial bladder cancer." Journal of cellular biochemistry. Supplement. 1992 16I:153-5.
1992
Messing EM, Reznikoff CA. "Epidermal growth factor and its receptor: markers of--and targets for--chemoprevention of bladder cancer." Journal of cellular biochemistry. Supplement. 1992 16I:56-62.
1992
Pink JC, Messing EM, Reznikoff CA, Bryan GT, Swaminathan S. "Correlation between N-acetyltransferase activities in uroepithelia and in vivo acetylator phenotype." Drug metabolism and disposition : the biological fate of chemicals.. 1992 20(4):559-65.
1992
Messing EM. "Growth factors and bladder cancer: clinical implications of the interactions between growth factors and their urothelial receptors." Seminars in surgical oncology.. 1992 8(5):285-92.
12/1991
Huland E, Huland H, Meier T, Baricordi O, Fradet Y, Grossman HB, Hodges GM, Messing EM, Schmitz-Draeger BJ. "Comparison of 15 monoclonal antibodies against tumor-associated antigens of transitional cell carcinoma of the human bladder." The Journal of urology.. 1991 Dec; 146(6):1631-6.
12/1991
Edelman GC, Sweet ME, Messing EM, Helgerson RB. "Treatment of severe electrical burns of the genitalia and perineum by early excision and grafting." Burns : journal of the International Society for Burn Injuries.. 1991 Dec; 17(6):506-9.
3/1991
Messing EM. "Interstitial cystitis." New York state journal of medicine.. 1991 Mar; 91(3):91-2.
11/1990
Dreicer R, Messing EM, Loehrer PJ, Trump DL. "Perioperative methotrexate, vinblastine, doxorubicin and cisplatin (M-VAC) for poor risk transitional cell carcinoma of the bladder: an Eastern Cooperative Oncology Group pilot study." The Journal of urology.. 1990 Nov; 144(5):1123-6; discussion 1126-7.
9/1990
Messing EM, Vaillancourt A. "Hematuria screening for bladder cancer." Journal of occupational medicine. : official publication of the Industrial Medical Association.. 1990 Sep; 32(9):838-45.
9/1990
Malec JF, Romsaas EP, Messing EM, Cummings KC, Trump DL. "Psychological and mood disturbance associated with the diagnosis and treatment of testis cancer and other malignancies." Journal of clinical psychology.. 1990 Sep; 46(5):551-7.
4/15/1990
Messing EM. "Clinical implications of the expression of epidermal growth factor receptors in human transitional cell carcinoma." Cancer research.. 1990 Apr 15; 50(8):2530-7.
12/1/1989
Messing EM, Young TB, Hunt VB, Wehbie JM, Rust P. "Urinary tract cancers found by homescreening with hematuria dipsticks in healthy men over 50 years of age." Cancer.. 1989 Dec 1; 64(11):2361-7.
10/1989
Goldrath DE, Messing EM. "Prostate specific antigen: not detectable despite tumor progression after radical prostatectomy." The Journal of urology.. 1989 Oct; 142(4):1082-4.
8/1989
Trump DL, Havlin KH, Messing EM, Cummings KB, Lange PH, Jordan VC. "High-dose ketoconazole in advanced hormone-refractory prostate cancer: endocrinologic and clinical effects." Journal of clinical oncology : official journal of the American Society of Clinical Oncology.. 1989 Aug; 7(8):1093-8.
1989
Messing. "Epidermal growth factor and bladder cancer: effects of urinary pH". EMSurg Forum. 1989; 40: 694-696.
1/15/1988
Messing EM, Hanson P, Reznikoff CA. "Normal and malignant human urothelium: in vitro response to blockade of polyamine synthesis and interconversion." Cancer research.. 1988 Jan 15; 48(2):357-61.
1988
Babel SG, McDermott JC, Goldrath DE, Crummy AB, Messing EM. "Case report and review of the literature: uretero-arterial fistula after balloon dilatation and stent placement". J Interven Radiol. 1988; 3: 135-138.
1988
Busch DB, Bryan GT, Easterling D, Leventhal H, Messing EM, Cummings KB. "Follow-up: recontacting subjects in mutagen exposure monitoring studies." IRB.. 1988 10(5):9-11.
11/1987
Messing EM, Hanson P, Ulrich P, Erturk E. "Epidermal growth factor--interactions with normal and malignant urothelium: in vivo and in situ studies." The Journal of urology.. 1987 Nov; 138(5):1329-35.
10/1987
Gillespie L, Messing EM. "When cystitis is suspected, what's the next step?" NAACOG newsletter. 1987 Oct; 14(10):1, 4-6.
5/1/1987
Messing EM, Reznikoff CA. "Normal and malignant human urothelium: in vitro effects of epidermal growth factor." Cancer research.. 1987 May 1; 47(9):2230-5.
5/1987
Messing EM, Young TB, Hunt VB, Emoto SE, Wehbie JM. "The significance of asymptomatic microhematuria in men 50 or more years old: findings of a home screening study using urinary dipsticks." The Journal of urology.. 1987 May; 137(5):919-22.
4/1987
Messing EM. "The diagnosis of interstitial cystitis." Urology.. 1987 Apr; 29(4 Suppl):4-7.
2/15/1987
Durzinsky DS, Messing EM, Myerowitz PD, Pellett JR, Wilson MA. "Method for assuring accuracy of bone biopsy using technetium 99 bone scan." Cancer.. 1987 Feb 15; 59(4):723-5.
2/1987
Messing EM. "Early stage bladder cancer." Wisconsin medical journal.. 1987 Feb; 86(2):14-7.
9/1986
Rodriguez PN, Hafez GR, Messing EM. "Nonseminomatous germ cell tumor of the testicle: does extensive staging of the primary tumor predict the likelihood of metastatic disease?" The Journal of urology.. 1986 Sep; 136(3):604-8.
6/1986
Fisher DT, Messing EM, Bruskewitz RC, Dibbell DG. "Use of loop double-lumen drainage system to prevent postoperative urinary diversion leaks." Urology.. 1986 Jun; 27(6):553.
2/15/1986
Messing EM, Love RR, Kvols LK. "Lymphocele after retroperitoneal node dissection for testis tumor." Cancer.. 1986 Feb 15; 57(4):871-4.
1986
Busch DB, Bryan GT, Messing EM, Cummings KB. "Recontacting subjects in mutagen exposure monitoring studies." IRB.. 1986 8(6):1-4.
12/1985
Messing EM, Dibbell DG, Belzer FO. "Bilateral rectus femoris pedicle flaps for detrusor augmentation in the prune belly syndrome." The Journal of urology.. 1985 Dec; 134(6):1202-5.
8/1985
Roach R, Messing E, Starling J. "Spontaneous thrombosis of left spermatic vein: report of 2 cases." The Journal of urology.. 1985 Aug; 134(2):369-70.
6/1985
Mohs FE, Snow SN, Messing EM, Kuglitsch ME. "Microscopically controlled surgery in the treatment of carcinoma of the penis." The Journal of urology.. 1985 Jun; 133(6):961-6.
1985
Messing EM, Hanson P, Waters P. "Ornithine decarboxylase activity and polyamine requirements of human bladder cancer". Surg Forum. 1985; 36: 651.
12/1984
Messing EM, Bubbers JE, Dekernion JB, Fahey JL. "Growth stimulating activity produced by human bladder cancer cells." The Journal of urology.. 1984 Dec; 132(6):1230-4.
12/1984
Schmidt WW, Messing EM, Reznikoff CA. "Cultures of normal human urothelial cells from ureters of perfused cadaver transplant kidneys." The Journal of urology.. 1984 Dec; 132(6):1262-4.
7/1984
Messing EM, Bubbers JE, Whitmore KE, deKernion JB, Nestor MS, Fahey JL. "Murine hybridoma antibodies against human transitional carcinoma-associated antigens." The Journal of urology.. 1984 Jul; 132(1):167-72.
1984
Messing EM. "Transforming growth factor from human bladder cancer". Surg Forum. 1984; 35: 662-664.
1983
Messing EM, Bubbers JE, deKernion JB, Fahey JL. "Growth stimulating activity produced by human bladder cancer cells". Surg Forum. 1983; 34: 683-687.
6/1982
Messing EM, Fahey JL, deKernion JB, Bhuta SM, Bubbers JE. "Serum-free medium for the in vitro growth of normal and malignant urinary bladder epithelial cells." Cancer research.. 1982 Jun; 42(6):2392-7.
12/1981
Messing E, deKernion JB. "Adjuvant therapy for genitourinary cancer." The Surgical clinics of North America.. 1981 Dec; 61(6):1331-46.
9/1981
Messing E, Tarsin M. "Antibody coating of bacteria persisting in a ureteral stump 10 years after nephrectomy." The Journal of urology.. 1981 Sep; 126(3):406-8.
9/1979
Messing EM, Henry SC. "Stones in orthotopic, non-obstructing ureteroceles." The Journal of urology.. 1979 Sep; 122(3):403-4.
4/1979
Messing EM, Freiha FS. "Complication of Clorpactin WCS90 therapy for interstitial cystitis." Urology.. 1979 Apr; 13(4):389-92.
1979
Freiha FS, Messing EM, Gross CM. "Emphysematous pyelonephritis". J Contin Educ Urol. 1979; : 9-19.
10/1978
Messing EM, Stamey TA. "Interstitial cystitis: early diagnosis, pathology, and treatment." Urology.. 1978 Oct; 12(4):381-92.
11/1976
Jahnke RW, Messing EM, Spellman MC. "Hypertension and post-traumatic renal arteriovenous fistula: demonstration of unilaterally elevated renin secretion." The Journal of urology.. 1976 Nov; 116(5):646-7.
8/1976
Messing E, Kessler R, Kavaney PB. "Renal arteriovenous fistulas." Urology.. 1976 Aug; 8(2):101-7.